Immunological Changes Through Narrative Treatment of Post-Traumatic Stress Disorder (PTSD) in Torture Victims

N/ACompletedNCT01206790

University of Konstanz47 enrolled

Overview

Posttraumatic stress disorder (PTSD) is associated with poor health, high health care utilization, and an increased risk for a variety of somatic, inflammatory and autoimmune diseases. Research, including our own findings, indicates immunological alterations in PTSD patients. The aim of this study is to investigate whether alterations in the immune system of PTSD patients are reversible through a trauma-specific short-term therapy (Narrative Exposure Therapy).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

PTSD

Interventions

NETBEHAVIORAL

Narrative Exposure Therapy for traumatized survivors of organized violence

Eligibility

Sex: ALLMin age: 16 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * PTSD diagnosis * experiences of organized violence/torture Exclusion Criteria: * psychotic disorder * chronic inflammatory diseases

Locations (1)

University of Konstanz, Department of Psychology

Konstanz, Germany

Outcomes

Primary Outcomes

PTSD diagnosis and severity score according to the Clinicians Administered PTSD Scale (CAPS)

Time frame: 4 month after completion of treatment

Secondary Outcomes

changes in immunological parameters

Time frame: 4 months after completion of treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.